Posted by The Bowdoin Group on March 30th, 2015
WELLESLEY, Mass., March 30, 2015 – The Bowdoin Group has been named one of the top 40 recruiters for biotechnology and pharmaceutical positions, unranked and listed in alphabetical order. That’s up from 24 firms in GEN’s 2013 List, and 32 such firms in last year’s List. Listings are based on information furnished by the companies on their websites and other publicly available material, including their LinkedIn and Twitter pages and press announcements.
Even with all the layoffs resulting from mergers and acquisitions, overall hiring in biopharma is projected to grow this year. The U.S. Bureau of Labor Statistics offers a rosier forecast depending on the position, projecting growth through 2022 of between 9% (for chemical technicians) and 41% (for genetic counselors). Trends like these should mean more work for biopharma recruiters, who match employers with job candidates in significant portions of the industry.
Originally published by Alex Philippidis Senior News Editor Genetic Engineering & Biotechnology News.
About The Bowdoin Group
Founded in 1994, The Bowdoin Group is an award-winning executive search firm that specializes in leadership and strategic roles for a wide range of companies, from small firms building out their executive team to large firms sourcing talent for rapid market expansion. With deep expertise in BioPharma, Digital Health, FinTech and Financial Services, and Software, The Bowdoin Group is a leader in the Greater Boston area with depth of experience in sourcing talent and servicing companies globally. The company’s service reputation earned it a ranking in the top 2% of the recruiting industry for client satisfaction. Bowdoin is active in supporting Boston’s entrepreneurial ecosystem as well as several non-profit causes.